RLD Procurement & Named Patient Program in Belgium | indiapharma exporter

India’s pharmaceutical industry has become the world’s backbone for affordable, high-quality medicines. By volume, India supplies about 20% of global generic drugs, and meets roughly 60% of global vaccine demand—a scale unmatched by most markets. Scale, Momentum, and Market Reach: India’s export engine keeps accelerating. Pharmaceutical exports touched roughly USD 30.47 billion in FY25, up 9.4% year-on-year, signaling healthy global demand despite pricing pressure and regulatory complexity. Indian manufacturers and exporters now supply medicines to 200+ countries, including the most highly regulated markets, reflecting deep distribution networks and regulatory maturity.       Quality Systems Trusted by Stringent Regulators: A core reason buyers trust India is its compliance footprint. India hosts the largest number of US-FDA–compliant pharmaceutical plants outside the United States, alongside facilities aligned to EMA, WHO-GMP, and other global standards. This dense ...